SENESTECH INC (SNES) Stock Price, Quote, News and Overview
NASDAQ:SNES - Nasdaq - US81720R6045 - Common Stock
SNES Quote and Key Statistics
SENESTECH INC
NASDAQ:SNES (1/22/2025, 10:21:58 AM)
2.98
-0.15 (-4.79%)
SNES Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -149.74% | ||
| ROE | -182.47% | ||
| Debt/Equity | 0.05 |
SNES Performance and Technical Analysis
SNES Ownership and Analysts
SNES Latest News and Analysis
Bug Off Pest Control Center of New York City to Supply New York City with Evolve™
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in humane pest control solutions, is pleased to announce that Evolve™...
Joshua M. Moss Joining the SenesTech Board of Directors
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), a pioneer in humane pest control solutions, is pleased to announce that Joshua M....
SenesTech Announces Third Quarter 2024 Financial Results
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), the leader in fertility control to manage animal pest populations and the only...
SenesTech to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
/PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its third quarter 2024, ended September 30, 2024, after the market close on...
About SNES
Company Profile
Senestech Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in Phoenix, Arizona and currently employs 25 full-time employees. The company went IPO on 2016-12-08. SenesTech, Inc. develops and commercializes products for managing animal pest populations, initially rat populations, through fertility control. The firm has two product lines of fertility control products: ContraPest and Evolve. Its product ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions of the rat population. ContraPest is a highly palatable liquid formulation that reduces fertility in both male and female rats. Additionally, ContraPest does not cause illness in rats, and, therefore, it does not change behavior or result in bait aversion. ContraPest offers a new tool used in coordination with rodenticides as part of an integrated pest management program. The firm's technology can also be applied to other mammalian species.
Company Info
SENESTECH INC
777 W. Pinnacle Peak Road, Suite B104
Phoenix ARIZONA 85027 US
CEO: Kenneth Siegel
Employees: 25
Company Website: https://senestech.com/
Investor Relations: https://senestech.investorroom.com/
Phone: 19287794143
SNES Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 73.94 | 713.84B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 27.54 | 362.06B | ||
| JNJ | JOHNSON & JOHNSON | 13.99 | 344.96B | ||
| MRK | MERCK & CO. INC. | 16.1 | 242.34B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 17.89 | 211.34B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.27 | 197.98B | ||
| PFE | PFIZER INC | 10.23 | 149.52B | ||
| SNY | SANOFI-ADR | 12.4 | 129.32B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 48.55 | 115.20B | ||
| ZTS | ZOETIS INC | 28.94 | 75.21B | ||
| GSK | GSK PLC-SPON ADR | 8.24 | 68.73B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 21.71 | 41.29B |